Skip to content
Austin Top 50
Author:
FesariusTherapeutics, Inc
FesariusTherapeutics Closes Oversubscribed $20M Series A, Led by Jefferson Life Sciences, and Backed by NY Ventures, and the American Society of Plastic Surgeons
June 10, 2026
Synergy CHC Corp. Reports First Quarter 2026 Financial Results
May 14, 2026
Fesarius Therapeutics demonstrates the science that establishes DermiSphere™ hDRT in a class of its own
April 30, 2026